Cargando…
Methodology for computing the burden of disease of adverse events following immunization
PURPOSE: Composite disease burden measures such as disability‐adjusted life‐years (DALY) have been widely used to quantify the population‐level health impact of disease or injury, but application has been limited for the estimation of the burden of adverse events following immunization. Our objectiv...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055877/ https://www.ncbi.nlm.nih.gov/pubmed/29575242 http://dx.doi.org/10.1002/pds.4419 |
_version_ | 1783341267824934912 |
---|---|
author | McDonald, Scott A. Nijsten, Danielle Bollaerts, Kaatje Bauwens, Jorgen Praet, Nicolas van der Sande, Marianne Bauchau, Vincent de Smedt, Tom Sturkenboom, Miriam Hahné, Susan |
author_facet | McDonald, Scott A. Nijsten, Danielle Bollaerts, Kaatje Bauwens, Jorgen Praet, Nicolas van der Sande, Marianne Bauchau, Vincent de Smedt, Tom Sturkenboom, Miriam Hahné, Susan |
author_sort | McDonald, Scott A. |
collection | PubMed |
description | PURPOSE: Composite disease burden measures such as disability‐adjusted life‐years (DALY) have been widely used to quantify the population‐level health impact of disease or injury, but application has been limited for the estimation of the burden of adverse events following immunization. Our objective was to assess the feasibility of adapting the DALY approach for estimating adverse event burden. METHODS: We developed a practical methodological framework, explicitly describing all steps involved: acquisition of relative or absolute risks and background event incidence rates, selection of disability weights and durations, and computation of the years lived with disability (YLD) measure, with appropriate estimation of uncertainty. We present a worked example, in which YLD is computed for 3 recognized adverse reactions following 3 childhood vaccination types, based on background incidence rates and relative/absolute risks retrieved from the literature. RESULTS: YLD provided extra insight into the health impact of an adverse event over presentation of incidence rates only, as severity and duration are additionally incorporated. As well as providing guidance for the deployment of DALY methodology in the context of adverse events associated with vaccination, we also identified where data limitations potentially occur. CONCLUSIONS: Burden of disease methodology can be applied to estimate the health burden of adverse events following vaccination in a systematic way. As with all burden of disease studies, interpretation of the estimates must consider the quality and accuracy of the data sources contributing to the DALY computation. |
format | Online Article Text |
id | pubmed-6055877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60558772018-07-30 Methodology for computing the burden of disease of adverse events following immunization McDonald, Scott A. Nijsten, Danielle Bollaerts, Kaatje Bauwens, Jorgen Praet, Nicolas van der Sande, Marianne Bauchau, Vincent de Smedt, Tom Sturkenboom, Miriam Hahné, Susan Pharmacoepidemiol Drug Saf Original Reports PURPOSE: Composite disease burden measures such as disability‐adjusted life‐years (DALY) have been widely used to quantify the population‐level health impact of disease or injury, but application has been limited for the estimation of the burden of adverse events following immunization. Our objective was to assess the feasibility of adapting the DALY approach for estimating adverse event burden. METHODS: We developed a practical methodological framework, explicitly describing all steps involved: acquisition of relative or absolute risks and background event incidence rates, selection of disability weights and durations, and computation of the years lived with disability (YLD) measure, with appropriate estimation of uncertainty. We present a worked example, in which YLD is computed for 3 recognized adverse reactions following 3 childhood vaccination types, based on background incidence rates and relative/absolute risks retrieved from the literature. RESULTS: YLD provided extra insight into the health impact of an adverse event over presentation of incidence rates only, as severity and duration are additionally incorporated. As well as providing guidance for the deployment of DALY methodology in the context of adverse events associated with vaccination, we also identified where data limitations potentially occur. CONCLUSIONS: Burden of disease methodology can be applied to estimate the health burden of adverse events following vaccination in a systematic way. As with all burden of disease studies, interpretation of the estimates must consider the quality and accuracy of the data sources contributing to the DALY computation. John Wiley and Sons Inc. 2018-03-24 2018-07 /pmc/articles/PMC6055877/ /pubmed/29575242 http://dx.doi.org/10.1002/pds.4419 Text en © 2018 The Authors. Pharmacoepidemiology & Drug Safety Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Reports McDonald, Scott A. Nijsten, Danielle Bollaerts, Kaatje Bauwens, Jorgen Praet, Nicolas van der Sande, Marianne Bauchau, Vincent de Smedt, Tom Sturkenboom, Miriam Hahné, Susan Methodology for computing the burden of disease of adverse events following immunization |
title | Methodology for computing the burden of disease of adverse events following immunization |
title_full | Methodology for computing the burden of disease of adverse events following immunization |
title_fullStr | Methodology for computing the burden of disease of adverse events following immunization |
title_full_unstemmed | Methodology for computing the burden of disease of adverse events following immunization |
title_short | Methodology for computing the burden of disease of adverse events following immunization |
title_sort | methodology for computing the burden of disease of adverse events following immunization |
topic | Original Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055877/ https://www.ncbi.nlm.nih.gov/pubmed/29575242 http://dx.doi.org/10.1002/pds.4419 |
work_keys_str_mv | AT mcdonaldscotta methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT nijstendanielle methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT bollaertskaatje methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT bauwensjorgen methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT praetnicolas methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT vandersandemarianne methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT bauchauvincent methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT desmedttom methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT sturkenboommiriam methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization AT hahnesusan methodologyforcomputingtheburdenofdiseaseofadverseeventsfollowingimmunization |